UNIGE document Scientific Article
previous document  unige:100420  next document
add to browser collection

Le point sur la tuberculose multirésistante en Suisse

Published in Revue médicale suisse. 2016, vol. 12, no. 539, p. 1948-1954
Abstract Multi-resistant tuberculosis (MDR-TB) is a world-wide public-health problem with about half a million cases/year (of a total of 9 million cases of TB). Patients at highest risk for MDR-TB are those who have already been treated. Among other risk factors are: contact with an index case of MDR-TB, being a migrant, and originating from a country with a high incidence of MDR-TB. Switzerland has had so far a relatively small number of MDR-TB cases, with a slight increase over the past few years. Use of PCR and genotypic antibiograms allow a rapid detection of MDR-TB cases as well as initiating a more adapted treatment, which must however be finally adjusted on the basis of the phenotypic antibiogram. Treatment is long, costly and tedious, even if, based on recent data, there is a hope for shorter treatments (9‑12 months).
PMID: 28696636
Full text
Article (Published version) (2.8 MB) - public document Free access
Research group Groupe Gasche-Soccal Paola (958)
(ISO format)
KNUCHEL, Judith et al. Le point sur la tuberculose multirésistante en Suisse. In: Revue médicale suisse, 2016, vol. 12, n° 539, p. 1948-1954. https://archive-ouverte.unige.ch/unige:100420

300 hits



Deposited on : 2017-12-15

Export document
Format :
Citation style :